WHO meeting with the Medical Technology Industry

World Health Organization7 May 2012 Geneva, Switzerland

DITTA Overview and ContributionNicole Denjoy, DITTA Vice Chair

Olivier Denève, DITTA Representative

Since our last meeting…

•DITTA established a presence on the web globalditta.org including a new logo and acronym

•DITTA and its members (currently: COCIR, JIRA, MEDEC and MITA) have the experience and expertise to advocate to all stakeholders and to share our competencies on behalf of the diagnostic imaging, radiation therapy, healthcare IT, electromedical and radiopharmaceutical industry

•DITTA members are working together more effectively than ever, and we look forward to becoming more engaged on concrete matters of interest with WHO and other international policymakers, professional associations and organizations

2

Our Focus• Our main focus: to improve quality, safety and patient access

• To promote “approved once, registered everywhere” with a harmonized global regulatory environment to ensure industry remains at the forefront of technological innovation, and continues to supply health care providers with innovative products in a sustainable, cost efficient system

• To achieve global harmonized regulatory frameworks: the use of international standards remain a key element as well as to facilitate trade and reduce cost of medical equipment through common, agreed and harmonized procedures

• To stimulate associations in emerging countries to join DITTA

3

ObjectivesCommunicate, cooperate and coordinate between associations to:1.Improve quality, safety and patient access around the globe2.Develop and advocate for industry positions with global industry impact3.Promote ethical conduct and practices4.Advocate for least burdensome policies and regulations that promote innovation5.Harmonize regulatory frameworks and product approval processes6.Leverage the benefits of international standards7.Enhance market access and global competitiveness of the industry8.Improve awareness and relevance of industry products in healthcare

4

We...Represent the global industry in these domains

5

In-vivo diagnosis, therapy and ICT: For the following benefits:

• Ultrasound• Medical X-ray• Computed tomography (CT)• Nuclear imaging• Positron emission tomography (PET) • Radiation therapy• Magnetic resonance imaging (MRI)• Imaging information• Medical software, Health ICT • Radiopharmaceuticals

• Leads to prevention and early detection of disease• Improves the quality of care• Supports eHealth Records• Reduces the likelihood of medical errors• Lowers long-term cost of health care

Update of Recent Activity• DITTA website www.globalditta.org• Support of IMDRF

– Transition of GHTF achievements– Foster broader collaboration of regulators, industry, and stakeholders– Contribute to IMDRF work item ‘Roadmap for implementation of a UDI

system’ and work item ‘Regulated Product Submission’– DITTA proposed to IMDRF a new work item on ‘Medical Software’

• Provide expertise and experience– Medical Software workshops for regulators, industry, and users– IEC 60601-1 3rd edition workshop for Asian target groups – CCPIE conferences in China– DITTA association radiation protection efforts (IAEA, HERCA)– Member company enhanced collaboration efforts with AHWP

6

www.globalditta.org

7

Open Letter to IMDRF Chair (Dec. 2011)

• Maintain value added of work/guidance done by GHTF during the past 20 years

• Work closely with AHWP• Accelerate global harmonization of medical device regulation• Promote and use efficiently international standards• Maintain and strengthen Standards Rapporteur position• Industry should have a key contributing role in IMDRF activities• DITTA ready to work with IMDRF to achieve mutually desired

objectives of promoting globally highest level of health and safety while continuing to innovate

8

IMDRF Stakeholders Meeting Presentation (Feb. 2012)

• Governance– IMDRF Management Committee should be open to industry– Commit to GHTF legacy– Promote greater transparency in their efforts

• Membership– Expand membership beyond five founding members– New members should commit to implement IMDRF decisions– IMDRF should clarify their relationship and work with relevant bodies, ex. AHWP, IEC, ISO and

WHO– IMDRF should be geographically balanced to ensure that everyone is heard

• Activities– Work toward “Registered once, approved everywhere”– Make strong commitment to international standards– Have working groups on medical software (only DITTA proposed a new item for consideration)– IMDRF to clearly indicate its goals and ambitions, and have an open attitude for industry's

proposals and proposed contributions to achieve them.

9

IMDRF Management Committee(April 2012)

• Pleased that Management Committee open to greater industry involvement, however…

• IMDRF prefers one industry representative:– Not possible for one individual to fully represent entire industry– Our letter reaffirmed DITTA’s strength as the only global association

representing medical imaging, which includes companies of all sizes all over the world

– In an effort to promote industry unity, DITTA approached GMTA about preparing a joint response, they declined

– As such DITTA has proposed it’s own representative• DITTA submitted a New Working Item Proposal on Medical Software• IMDRF Chair, Dr. Kelly, welcomed DITTA’s remarks and the Management

Committee will discuss our letter at their next meeting on June 5, 2012.

10

Medical Software

• To further illustrate our commitment to IMDRF, DITTA prepared a New Work Item Proposal based on a IMDRF template at the request of the Management Committee to consider medical software as a future IMDRF work item

• DITTA is currently working to prepare another medical software workshop later this year after the successful workshop in Brussels last October 2011

11

Other Activities• DITTA will host a workshop on IEC 60601-1 third edition in China later

this year with SFDA as part of the US China Joint Commission on Commerce and Trade (JCCT)

• DITTA is seeking to incorporate and is developing its own by-laws after a successful annual meeting last December at RSNA where we reached consensus among membership on an organizational and governance model– This includes scope, objectives, decision making and approval

processes, criteria for membership, meeting guidelines, association priorities, etc.

– DITTA association executives signed a commitment letter to further illustrate their pledge to support and strengthen DITTA

• Several DITTA member companies completed the WHO survey on “access to medical devices”

12

Conclusion• DITTA is enhancing its network across the globe to better understand the

needs of stakeholders and to support efforts in line with our focus and objectives

• DITTA is interested to learn more about WHO’s interests, and appreciates the invitation to continue this dialogue

• We look forward to expanding this important relationship in the interest of patient safety and access to advanced medical imaging technologies

• DITTA members are committed to support WHO initiatives for “safe, effective, and affordable technology for very low resource settings for use at point of care”

13

Thank You

14